Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature

• Prif Awduron: Ottavia Bernocchi (Awdur), Marianna Sirico (Awdur), Silvia Paola Corona (Awdur), Carla Strina (Awdur), Manuela Milani (Awdur), Maria Rosa Cappelletti (Awdur), Giuseppina Ferrero (Awdur), Nicoletta Ziglioli (Awdur), Valeria Cervoni (Awdur), Andrea Macchiavelli (Awdur), Giandomenico Roviello (Awdur), Daniele Generali (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2021-02-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in different cancer types. Tumor type agnostic therapy is based on targetin...